Friday, January 30, 2026

South Korea’s Short Track Team Faces Tall Order: Aiming for 9 Golds, But China Stands in the Way

South Korea aims for a historic clean sweep of gold medals in short track at the 2025 Asian Games, facing fierce competition from China.

Kim Ji Seok and Lee Joo Myung: Surprising New Couple With a 13-Year Age Difference”

Kim Ji Seok and Lee Joo Myung are dating, confirmed by their agencies, appreciating support for their relationship.

Health

How a 2-Cent Sugar Tax Could Save $4.5 Billion in Healthcare Costs: California’s Bold Move

A sugar-sweetened beverage tax in California could cut obesity cases and save $4.5 billion in healthcare costs over ten years.

Unlocking Global Potential: ezCaretech’s AI-Driven Healthcare Solutions for Saudi Arabia

ezCaretech is expanding into the Middle East, focusing on Saudi Arabia, with innovative healthcare technology and global partnerships.

Celltrion’s Zymfentra: How This Breakthrough Drug is Driving Record Sales

Celltrion expects record sales driven by Zymfentra's success, expanding into new biosimilars and CDMO business for future growth.

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Chinese Biotech’s Rise: What’s the Standard of Global Tech Trade?

Analysts at the JPMHC noted a shift in biotech, with firms resisting sales and China emerging as a tech transfer leader.

Latest Neonatal Resuscitation Guidelines: Key Insights for Healthcare Professionals

GE Healthcare Korea held a webinar on neonatal resuscitation guidelines to enhance perinatal care and improve treatment outcomes.

Revolutionizing Pharma: How LG CNS’s Agentic AI is Set to Transform Drug Development in South Korea

LG CNS expands its AI Transformation business into pharma, enhancing drug development with AI-driven platforms and automation services.

Novo Nordisk’s Oral Wegovy Tops 3,000 Prescriptions in Its First Week—A Challenge to Injectable GLP-1s

Novo Nordisk's Wegovy oral treatment exceeds 3,000 prescriptions in its debut week, signaling a shift towards oral obesity medications.

From Hair Loss to Inflammation: JW Pharmaceutical Showcases Pipeline to Global Pharma at JPMorgan

JW Pharmaceutical participated in the JP Morgan Healthcare Conference, discussing potential drug partnerships and licensing deals.

Botox Faces New Challenger: Chong Kun Dang’s Toxin Shows Non-Inferiority in China Study

Chong Kun Dang's CKDB-501A shows non-inferiority to Botox in Phase 3 trials for treating glabellar lines, with promising safety data.

Korea Clears New Probiotic Claim: hy’s HY7017 Shows Immune Gains in Human Trials

hy's probiotic strain HY7017 has been approved for immune enhancement, adding to its portfolio of nine recognized ingredients.

NK Cell Cancer Therapies Move Closer to Market as Matica BioLabs Partners With Ingenium

CHA Biotech's Matica BioLabs partners with Ingenium Therapeutics for NK cell therapy production, targeting cancer treatment advancements.

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

JLK’s Stroke AI Goes Subscription-Based as University Hospitals Drive Adoption

JLK's stroke AI solution enhances diagnosis and treatment at Chung-Ang University Hospital, improving patient care and revenue growth.

2025’s Drug Price Revolution: What Asian Pharma Firms Need to Know About MFN Policies

Trump's second term sees U.S. drug pricing reforms and supply chain shifts, prompting South Korean firms to seize new opportunities.

Weight-Loss Drugs Could Cut Airline Fuel Bills by $580 Million—An Unexpected Win for U.S. Carriers

The obesity treatment market is growing, helping U.S. airlines save on fuel costs due to decreased passenger weight.

Does Tylenol Raise Autism Risk? What a Review of 43 Studies and 1 Million Children Shows

A European study confirms Tylenol's safety during pregnancy, countering claims linking it to autism, ADHD, and intellectual disabilities.

Novo Nordisk’s Wegovy Pill Draws 3,000 Prescriptions in Its First Week—Is Oral GLP-1 Here to Stay?

Novo Nordisk's Wegovy oral obesity treatment saw over 3,000 prescriptions in its first week, indicating strong market demand.

ABL206: First-in-Class Dual Antibody Drug Conjugate Approved for Clinical Trials in the U.S. – What This Means for Cancer Treatment

ABL Bio and Neok Bio received FDA approval for ABL206, a dual-antibody ADC, marking a key milestone in their clinical development efforts.

Top News

- Our Sponsors Ad -

Follow us